Document is current
Any future updates will be listed below
-
Authors
Cox, Kristin E.
Turner, Michael A.
Lwin, Thinzar M.
Amirfakhri, Siamak
Kelly, Kaitlyn J.
Hosseini, Mojgan
Ghosh, Pradipta
Obonyo, Marygorret
Hoffman, Robert M.
Yazaki, Paul J.
Bouvet, Michael https://orcid.org/0000-0002-0086-2159
-
Funding
Funding for this research was provided by:
Department of Defense (W81XWH-20-1-0675)
VA Merit Review (1 I01 BX003856-01A1)
VA Merit Review (1 I01 BX004494-01)
Padres Pedal the Cause Collaborative Translational Pilot Project (PTC2021)
Padres Pedal the Cause Collaborative Translational Pilot Project (PTC2022)
National Institutes of Health (R01 CA100768)
National Institutes of Health (R01 CA238042)
National Institutes of Health (R01 CA256973-01)
National Institutes of Health (T32 CA121938)
Torrey Coast Foundation
National Cancer Institute (CCSG Grant P30CA23100)
- License Information
-
More Information
Article History
Received: 2 April 2024
Accepted: 21 May 2024
First Online: 18 June 2024
Disclosure
: RMH is a non-salaried affiliate of Anti Cancer, Inc. which produces patient-derived orthotopic xenograft (PDOX) mouse models for contract research. PY declares a patent covering anti-CEA M5A antibody for fluorescence guided surgery.
